El Segundo-based Vantage Oncology has raised $15M from New Enterprise Associates, Conning Capital Partners, Salix Ventures, and Versant Ventures. Vantage operates centers for the treatment of cancer, using advanced radiation oncology. The Series B round included NEA as the lead and new investor. The company is headed by Michael T. Fiore, former President of Comprehensive Cancer Centers and COO of Salick Health Care. More information »